0.3230
-0.0020
(-0.62%)
At close: April 17 at 5:35:19 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-8,662
-8,662
-8,212
-7,393
-8,368
Investing Cash Flow
-1,765
-1,765
-7,286
-4,747
-2,050
Financing Cash Flow
5,686
5,686
5,389
26,311
14,233
End Cash Position
11,162
11,162
15,902
26,010
11,840
Capital Expenditure
-2,424
-2,424
-5,165
-4,322
-3,124
Issuance of Capital Stock
73
73
4,549
30,238
7,847
Issuance of Debt
6,412
6,412
1,492
1,391
7,470
Repayment of Debt
-750
-750
-525
-5,050
-880
Repurchase of Capital Stock
-22
-22
-94
--
--
Free Cash Flow
-11,086
-11,086
-13,377
-11,715
-11,492
12/31/2020 - 4/16/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALBPS.PA Biophytis S.A.
0.1800
+4.65%
ALNEV.PA Neovacs S.A.
0.0219
-3.52%
MOLN.SW Molecular Partners AG
3.1600
-3.66%
GNFT.PA Genfit S.A.
3.0700
-1.98%
MLTX MoonLake Immunotherapeutics
38.33
+3.67%
RANI Rani Therapeutics Holdings, Inc.
1.1700
+1.74%
NAMS NewAmsterdam Pharma Company N.V.
16.34
+1.93%
VTYX Ventyx Biosciences, Inc.
1.0700
+0.94%
GOSS Gossamer Bio, Inc.
0.8425
+1.49%
TNYA Tenaya Therapeutics, Inc.
0.4500
-2.58%